Target Corporation (TGT) REVENUE $

 Target Corporation (TGT) REVENUE $

PYRAMID SHEME

 

CUT THE DAMAGE

 

When you find a crack in the stock market...

Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian

 

The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-risk transient ischemic attack involving up to 30,000 patients / Bayer drives the development of its FXIa inhibitor, with the goal of offering a potential new class of antithrombotics for improved outcomes for patients using selective coagulation modulation

stock market and butterfly

Which is the key for the stock market?

What do equity values look like?

What can cause you stock market myopia?

BAIC MOTOR: CURRENT PRICE VS GRAHAM NUMBER